| Phase 01 trial |
|
Phase 0
|
NCT03599453 |
Jan 2019 → Sep 2020 |
triple-negative breast carcinoma |
Roswell Park Cancer Institute |
Completed
|
No outcome recorded
|
| Phase 13 trials |
|
Phase 1
|
NCT04081389 |
Dec 2019 → May 2022 |
breast carcinoma in situ, triple-negative breast carcinoma |
Roswell Park Cancer Institute |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00000713 |
? → Oct 1992 |
HIV infectious disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00000735 |
? → Feb 1990 |
HIV infectious disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
Completed
|
No outcome recorded
|
| Phase 1/210 trials |
|
Phase 1/2
|
NCT05756166 |
Feb 2024 → Apr 2025 |
female breast carcinoma, triple-negative breast carcinoma |
Roswell Park Cancer Institute |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT05927142 |
Jan 2024 → Apr 2026 overdue |
pancreatic ductal adenocarcinoma |
Joachim Aerts, MD PhD |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT04379518 |
Nov 2020 → Mar 2023 |
COVID-19, cancer, hematopoietic and lymphoid cell neoplasm |
Roswell Park Cancer Institute |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT03734692 |
Jan 2019 → Jul 2024 overdue |
ovarian carcinoma |
Robert Edwards |
Active not recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT02432378 |
Sep 2015 → Jun 2025 |
ovarian cancer |
Roswell Park Cancer Institute |
Withdrawn
|
No outcome recorded
|
|
Phase 1/2
|
NCT02151448 |
Jul 2014 → Feb 2019 |
malignant pancreatic neoplasm, malignant peritoneal mesothelioma, peritoneal carcinomatosis |
David Bartlett |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT01545141 |
Oct 2012 → Apr 2016 |
colorectal carcinoma |
Roswell Park Cancer Institute |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT01591473 |
Apr 2012 → Sep 2014 |
influenza |
AIM ImmunoTech Inc. |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT01355393 |
Jul 2011 → Nov 2013 |
HER2 positive breast carcinoma, male breast carcinoma |
University of Washington |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT01312389 |
Apr 2011 → May 2012 |
fallopian tube cancer, ovarian cancer, primary peritoneal carcinoma |
Abramson Cancer Center at Penn Medicine |
Terminated
|
No outcome recorded
|
| Phase 210 trials |
|
Phase 2
|
NCT07634094 |
Aug 2026 → Aug 2028 expected |
ovarian cancer |
Kalinski, Pawel, MD, PhD |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05494697 |
Jun 2026 → Dec 2029 |
malignant pancreatic neoplasm |
AIM ImmunoTech Inc. |
Suspended
|
No outcome recorded
|
|
Phase 2
|
NCT04093323 |
Nov 2024 → Apr 2025 |
— |
Roswell Park Cancer Institute |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT05592418 |
Jun → Nov 2023 |
long COVID-19 |
AIM ImmunoTech Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT04119830 |
Feb 2022 → Feb 2024 |
colorectal adenocarcinoma |
Roswell Park Cancer Institute |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT03899987 |
Nov 2019 → Apr 2027 expected |
prostate adenocarcinoma |
Roswell Park Cancer Institute |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT03403634 |
Apr 2018 → Dec 2020 |
colorectal carcinoma, metastatic carcinoma |
Roswell Park Cancer Institute |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT02615574 |
Mar 2016 → Jun 2018 |
colorectal cancer |
Pawel Kalinski |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT00035581 |
May 2001 → Sep 2005 |
HIV infectious disease |
AIM ImmunoTech Inc. |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT00035893 |
May 2001 → Aug 2006 |
HIV infectious disease |
AIM ImmunoTech Inc. |
Completed
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT00215800 |
Dec 1998 → Feb 2004 |
myalgic encephalomeyelitis/chronic fatigue syndrome |
AIM ImmunoTech Inc. |
Completed
|
No outcome recorded
|
| Phase not applicable2 trials |
| — |
NCT00001000 |
? → Jan 1990 |
HIV infectious disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
Completed
|
No outcome recorded
|
| — |
NCT00002269 |
— |
HIV infectious disease |
HEM Research |
Completed
|
No outcome recorded
|
| Phase not stated1 trial |
| — |
NCT00215813 |
— |
myalgic encephalomeyelitis/chronic fatigue syndrome |
AIM ImmunoTech Inc. |
Temporarily not available
|
No outcome recorded
|